Researchers at the Broad Institute of MIT and Harvard have developed a gene-editing treatment for prion disease that extends ...

If you're an investor searching for the next big market winners, Wall Street analysts have zeroed in on one biotech stock ...

The "CRISPR-based Gene Editing Market by Product & Service, by Application, by End-User, and By Region" report has been added ...

Synthego granted global license to manufacture and distribute AZ's CRISPR gene editing enzyme, eSpOT-ON.

The new Express License service removes barriers to accessing this transformative gene editing technology for startups.An ...

ON CRISPR enzyme, will combine with RNA guides for pharma customers. Deal follows HuidaGene agreement, offers 99% cost ...

Ongoing launch of CASGEVY® continues to gain momentum- -2025 is poised to be a catalyst-rich year with key updates across ...

Lehigh University bioenginering researcher Tomas Gonzalez-Fernandez recently secured funding through the National Science ...

The revolution in artificial intelligence (AI) and genetic engineering represents an unprecedented turning point in human ...

This Fool has his eye on an innovative growth stock that has plunged by 80% since early 2021. But what is so special about it ...